Interventions supporting cancer patients in making decisions regarding participation in clinical trials - a systematic review by Line Hillersdal, Zandra Engelbak Nielsen, Ane Taudorf Nørmark, Ann Knoop, Karin Piil

Get full text

Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients by Thomas Christensen, Tobias Berg, Lise Birk Nielsen, Michael Andersson, Maj-Britt Jensen, Ann Knoop

Get full text

Survival outcomes for HER2-low breast cancer: Danish national data by Michael Sode, Kåre Nielsen, Maj-Britt Jensen, Tobias Berg, Ann Knoop, Bent Ejlertsen, Anne-Vibeke Lænkholm

Get full text

High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients by Kåre Nielsen, Michael Sode, Maj-Britt Jensen, Tobias Berg, Ann Knoop, Bent Ejlertsen, Anne-Vibeke Lænkholm

Get full text

Intratumor Genetic Heterogeneity of Breast Carcinomas as Determined by Fine Needle Aspiration and TaqMan Low Density Array by Maria B. Lyng, Anne-Vibeke Lænkholm, Niels Pallisgaard, Werner Vach, Ann Knoop, Martin Bak, Henrik J. Ditzel

Get full text

Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study. by Maria B Lyng, Anne-Vibeke Lænkholm, Qihua Tan, Werner Vach, Karina H Gravgaard, Ann Knoop, Henrik J Ditzel

Get full text

Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer by Alan Celik, Tobias Berg, Maj-Britt Jensen, Erik Jakobsen, Hanne Melgaard Nielsen, Iben Kümler, Vesna Glavicic, Jeanette Dupont Jensen, Ann Knoop

Get full text

Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study by Alan Celik, Tobias Berg, Magnus Gibson, Maj-Britt Jensen, Iben Kümler, Saskia Eßer-Naumann, Erik H. Jakobsen, Ann Knoop, Dorte Nielsen

Get full text

Publisher Correction: Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer by Mathilde Louise Gehrchen, Tobias Berg, Rasmus Garly, Maj-Britt Jensen, Saskia Eßer-Naumann, Jeanette Dupont Rønlev, Hanne Melgaard Nielsen, Ann Knoop, Iben Kümler

Get full text

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer by Mathilde Louise Gehrchen, Tobias Berg, Rasmus Garly, Maj-Britt Jensen, Saskia Eßer-Naumann, Jeanette Dupont Rønlev, Hanne Melgaard Nielsen, Ann Knoop, Iben Kümler

Get full text